Skip to content

New integrase inhibitor bictegravir works well for first-line HIV treatment

Joel Gallant presents new data on bictegravir at IAS2017. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C treatment is effective and feasible in Africa

Karine Lacombe of Saint-Antoine Hospital, Paris, at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

High uptake of HIV self-testing by female sex workers in African countries

Sue Mavedzenge at IAS 2017. Photo by Roger Pebody, aidsmap.com

South African child has controlled HIV off treatment for 8.5 years

South African child has controlled HIV off treatment for 8.5 years

Programme to provide free self-tests helps gay men to test for HIV more often

Robin MacGowan at IAS 2017. Photo by Roger Pebody, aidsmap.com

Less frequent clinic visits for HIV care: fine tuning needed

MSF Community Adherence Club KwaZulu-Natal. Photo by Greg Lomas / Scholars and Gentlemen / Médecins sans Frontières

Improved treatment for cryptococcal meningitis in HIV could save thousands of lives – if generic drug becomes available

Sile Molloy at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

Swaziland: new infections halved in five years as HIV treatment scales up

Velephi Okello at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

Joseph Eron at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com